Literature DB >> 12038877

Severe heart failure in the elderly: potential benefits of high-dose and continuous infusion diuretics.

Patricia A Howard1, Marvin I Dunn.   

Abstract

Heart failure (HF) is a growing problem among the elderly that results in significant morbidity and mortality. Congestive symptoms because of sodium and water retention are a major cause of impaired functional capacity and frequent hospitalisations. Patients with severe HF often develop resistance to traditional doses of diuretics. Subtherapeutic diuretic regimens may result in prolonged hospitalisation and thus increased costs. Numerous studies have shown that aggressive high-dose regimens of loop diuretics can be safely and effectively used in elderly patients with severe HF. Continuous intravenous infusions are a particularly effective method for delivering high daily doses of diuretics and rapidly removing large amounts of excess sodium and water. In our experience, continuous intravenous infusions are a well tolerated and effective treatment, which may shorten the duration of hospitalisation and in turn reduce the costs of treating elderly patients with HF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12038877     DOI: 10.2165/00002512-200219040-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  22 in total

1.  AHA medical/scientific statement. 1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart.

Authors: 
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

2.  Severe musculoskeletal symptoms during continuous infusion of bumetanide.

Authors:  P A Howard; M I Dunn
Journal:  Chest       Date:  1997-02       Impact factor: 9.410

3.  Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.

Authors:  T P Dormans; J J van Meyel; P G Gerlag; Y Tan; F G Russel; P Smits
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

4.  Aggressive diuresis for severe heart failure in the elderly.

Authors:  P A Howard; M I Dunn
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

5.  Need and prospects for prevention of cardiac failure.

Authors:  W B Kannel
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

6.  Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance.

Authors:  J J van Meyel; P Smits; T Dormans; P G Gerlag; F G Russel; F W Gribnau
Journal:  J Intern Med       Date:  1994-04       Impact factor: 8.989

7.  Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure).

Authors: 
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

8.  Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

Authors:  R Garg; S Yusuf
Journal:  JAMA       Date:  1995-05-10       Impact factor: 56.272

9.  Furosemide in patients with heart failure: shift in dose-response curves.

Authors:  D C Brater; P Chennavasin; R Seiwell
Journal:  Clin Pharmacol Ther       Date:  1980-08       Impact factor: 6.875

10.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

View more
  1 in total

1.  Glomerular filtration rate in the elderly and in the oldest old: correlation with frailty and mortality.

Authors:  Alberto Montesanto; Francesco De Rango; Maurizio Berardelli; Vincenzo Mari; Fabrizia Lattanzio; Giuseppe Passarino; Andrea Corsonello
Journal:  Age (Dordr)       Date:  2014-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.